These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 16299808)
1. Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours. Fauvet R; Dufournet C; Poncelet C; Uzan C; Hugol D; Daraï E J Surg Oncol; 2005 Dec; 92(4):337-43. PubMed ID: 16299808 [TBL] [Abstract][Full Text] [Related]
2. Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours. Fauvet R; Poncelet C; Hugol D; Lavaur A; Feldmann G; Daraï E Virchows Arch; 2003 Jul; 443(1):38-43. PubMed ID: 12756564 [TBL] [Abstract][Full Text] [Related]
3. Expression of apoptosis-related proteins in peritoneal, ovarian and colorectal endometriosis. Dufournet C; Uzan C; Fauvet R; Cortez A; Siffroi JP; Daraï E J Reprod Immunol; 2006 Jun; 70(1-2):151-62. PubMed ID: 16378643 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors. Ozer H; Yenicesu G; Arici S; Cetin M; Tuncer E; Cetin A Diagn Pathol; 2012 Sep; 7():124. PubMed ID: 22995373 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax). de la Torre FJ; García A; Gil-Moreno A; Planaguma J; Reventos J; Ramón y Cajal S; Xercavins J Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):121-8. PubMed ID: 16876311 [TBL] [Abstract][Full Text] [Related]
6. Expression of Bcl-2 family proteins in psoriasis. Batinac T; Zamolo G; Hadzisejdić I; Zauhar G; Brumini G; Ruzić A; Persić V Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974 [TBL] [Abstract][Full Text] [Related]
7. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins. Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935 [TBL] [Abstract][Full Text] [Related]
9. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322 [TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related]
12. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2. Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475 [TBL] [Abstract][Full Text] [Related]
13. [Expression of AIB1 protein in epithelial ovarian cancer cells and its impact on apoptosis]. Han XY; Chen Y; Hou MM; Zhang J; Yang KX; Chen YY; Qie MR Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):619-22, 634. PubMed ID: 18798508 [TBL] [Abstract][Full Text] [Related]
14. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969 [TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms. O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma. Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of Bak expression in oral tongue squamous cell carcinomas. Xie X; Clausen OP; Boysen M Oncol Rep; 2003; 10(2):369-74. PubMed ID: 12579274 [TBL] [Abstract][Full Text] [Related]
18. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer. Borner MM; Brousset P; Pfanner-Meyer B; Bacchi M; Vonlanthen S; Hotz MA; Altermatt HJ; Schlaifer D; Reed JC; Betticher DC Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896 [TBL] [Abstract][Full Text] [Related]
19. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis. Rochaix P; Krajewski S; Reed JC; Bonnet F; Voigt JJ; Brousset P J Pathol; 1999 Mar; 187(4):410-5. PubMed ID: 10398099 [TBL] [Abstract][Full Text] [Related]
20. Significance of apoptosis related proteins on malignant transformation of ovarian tumors: A comparison between Bcl-2/Bax ratio and p53 immunoreactivity. Zeren T; Inan S; Vatansever HS; Sayhan S Acta Histochem; 2014 Oct; 116(8):1251-8. PubMed ID: 25108507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]